SIGHT SCIENCES, INC. Increase (Decrease) in Accounts Receivable
SIGHT SCIENCES, INC. (SGHT) reported Increase (Decrease) in Accounts Receivable of $1.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- SIGHT SCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $831.00K, a 286.51% increase year-over-year.
- SIGHT SCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $722.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $102.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $98.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$912.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2024 was -$3.54M.
- SIGHT SCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$661.00K, a 109.66% decline from fiscal 2022.
- SIGHT SCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2022 was $6.84M, a 85.19% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $831.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.55M 10-Q · filed 2026-08-05 | $1.66M derived: sum of 3 quarters · filed 2026-08-05 | $1.75M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $722.00K 10-Q · filed 2026-05-06 | $824.00K derived: sum of 2 quarters · filed 2026-05-06 | $922.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $200.00K derived: sum of 2 quarters · filed 2026-03-04 | $415.00K derived: sum of 3 quarters · filed 2026-08-05 | -$912.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $313.00K derived: sum of 2 quarters · filed 2026-08-05 | -$1.01M 10-Q · filed 2025-11-06 | -$3.13M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $215.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.11M 10-Q · filed 2026-08-05 | -$3.23M derived: sum of 3 quarters · filed 2026-08-05 | -$10.39M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.33M 10-Q · filed 2026-05-06 | -$3.44M derived: sum of 2 quarters · filed 2026-05-06 | -$10.61M derived: sum of 3 quarters · filed 2026-05-06 | -$6.26M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$9.28M derived: sum of 2 quarters · filed 2026-03-04 | -$4.93M derived: sum of 3 quarters · filed 2026-03-04 | -$3.54M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$7.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.82M derived: sum of 2 quarters · filed 2025-11-06 | -$1.43M 10-Q · filed 2025-11-06 | -$4.28M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $4.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $5.73M 10-Q · filed 2025-08-07 | $2.89M derived: sum of 3 quarters · filed 2025-08-07 | $2.08M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.39M 10-Q · filed 2025-05-08 | -$1.46M derived: sum of 2 quarters · filed 2025-05-08 | -$2.27M derived: sum of 3 quarters · filed 2025-05-08 | -$230.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$3.66M derived: sum of 2 quarters · filed 2025-03-07 | -$1.62M derived: sum of 3 quarters · filed 2025-03-07 | -$661.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | -$808.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.23M derived: sum of 2 quarters · filed 2024-11-07 | $2.19M 10-Q · filed 2024-11-07 | $4.75M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $3.00M 10-Q · filed 2024-08-02 | $5.56M derived: sum of 3 quarters · filed 2024-08-02 | $7.97M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $959.00K 10-Q · filed 2024-05-06 | $3.52M derived: sum of 2 quarters · filed 2024-05-06 | $5.93M derived: sum of 3 quarters · filed 2024-05-06 | $6.62M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $4.97M derived: sum of 2 quarters · filed 2024-03-13 | $5.66M derived: sum of 3 quarters · filed 2024-03-13 | $6.84M 10-K · filed 2024-03-13 |
| 2022-09-30 | $2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.10M derived: sum of 2 quarters · filed 2023-11-07 | $4.28M 10-Q · filed 2023-11-07 | $4.27M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $690.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.87M 10-Q · filed 2023-08-07 | $1.86M derived: sum of 3 quarters · filed 2023-08-07 | $3.94M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $1.18M 10-Q · filed 2023-05-08 | $1.17M derived: sum of 2 quarters · filed 2023-05-08 | $3.25M derived: sum of 3 quarters · filed 2023-05-08 | $4.57M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $2.07M derived: sum of 2 quarters · filed 2023-03-16 | $3.39M derived: sum of 3 quarters · filed 2023-03-16 | $3.69M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.41M derived: sum of 2 quarters · filed 2022-11-10 | $3.71M 10-Q · filed 2022-11-10 | $4.01M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.63M 10-Q · filed 2022-08-11 | $1.94M derived: sum of 3 quarters · filed 2022-08-11 | $3.98M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $301.00K 10-Q · filed 2022-05-10 | $608.00K derived: sum of 2 quarters · filed 2022-05-10 | $2.66M derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $2.36M derived: sum of 2 quarters · filed 2022-03-24 | $1.48M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.17M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$880.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |